Migrasomes: From Biogenesis, Release, Uptake, Rupture to Homeostasis and Diseases
Overview
Endocrinology
Authors
Affiliations
Migrasomes are migration-dependent membrane-bound vesicular structures that contain cellular contents and small vesicles. Migrasomes grow on the tips or intersections of the retraction fibers after cells migrate away. The process of releasing migrasomes into the extracellular space is named as "migracytosis". After releasing, they can be taken up by the surrounding cells, or rupture and further release their contents into the extracellular environment. Physiologically, migrasomes provide regional cues for organ morphogenesis during zebrafish gastrulation and discard the damaged mitochondria in response to mild mitochondrial stresses. Pathologically, migrasomes are released from podocyte during early podocyte stress and/or damage, from platelets after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from microglia/macrophages of the ischemic brain, and from tumor necrosis factor (TNF)-activated endothelial cells (ECs); thus, this newly discovered extracellular vesicle is involved in all these pathological processes. Moreover, migrasomes can modulate the proliferation of cancer cell lateral transferring mRNA and protein. In this review, we will summarize the biogenesis, release, uptake, and rupture of migrasomes and discuss its biological roles in development, redox signalling, innate immunity and COVID-19, cardio-cerebrovascular diseases, renal diseases, and cancer biology, all of these highlight the importance of migrasomes in modulating body homeostasis and diseases.
Polyelectrolytes Are Effective Cryoprotectants for Extracellular Vesicles.
Karnas E, Zajac M, Kmiotek-Wasylewska K, Kaminski K, Yusa S, Kedracka-Krok S ACS Appl Mater Interfaces. 2024; 16(51):70174-70186.
PMID: 39667739 PMC: 11672232. DOI: 10.1021/acsami.4c11852.
Extracellular Vesicles & Co.: scaring immune cells in the TME since ever.
Rodolfo C, Campello S Front Immunol. 2024; 15:1451003.
PMID: 39267748 PMC: 11390669. DOI: 10.3389/fimmu.2024.1451003.
Zhu Y, Chen Y, Xu J, Zu Y Biomedicines. 2024; 12(7).
PMID: 39062199 PMC: 11274667. DOI: 10.3390/biomedicines12071626.
Mitochondria in COVID-19: from cellular and molecular perspective.
Rurek M Front Physiol. 2024; 15:1406635.
PMID: 38974521 PMC: 11224649. DOI: 10.3389/fphys.2024.1406635.
Novel insights into the roles of migrasome in cancer.
Deng S, Wu Y, Huang S, Yang X Discov Oncol. 2024; 15(1):166.
PMID: 38748047 PMC: 11096295. DOI: 10.1007/s12672-024-00942-0.